No article text was recorded for this version.
lead compound optimization
Version 2 of 2114 papers118 conceptsfrozen 2026-10-04
Papers in this version
- Blog: High Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Non-Covalent Inhibitor
- Blog: Streptothricin F is a bactericidal antibiotic effective against highly drug-resistant gram-negative bacteria that interacts with the 30S subunit of the 70S ribosome
- Blog: Correction: A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination
- Blog: Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study
- Blog: Design, Synthesis and Antifungal Activity of 3-substituedmethylenethiochroman-4-one Derivatives
- Blog: Characterization of natural product inhibitors of quorum sensing in <i>Pseudomonas aeruginosa</i> reveals competitive inhibition of RhlR by <i>ortho</i> -vanillin
- Blog: The traditional chinese medicine monomer Ailanthone improves the therapeutic efficacy of anti-PD-L1 in melanoma cells by targeting c-Jun
- Blog: Fangchinoline inhibits growth and biofilm of <i>Candida albicans</i> by inducing <scp>ROS</scp> overproduction
- Blog: An Integrated Deep Learning and Molecular Dynamics Simulation-Based Screening Pipeline Identifies Inhibitors of a New Cancer Drug Target TIPE2
- Blog: Design, Synthesis, and Biological Evaluation of 4,4’-Difluorobenzhydrol Carbamates as Selective M1 Antagonists
- Blog: Combined Approaches for Drug Design Points the Way to Novel Proline Racemase Inhibitor Candidates to Fight Chagas’ Disease
- Blog: Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods
- Blog: A small-molecule inhibitor of the BRCA2-RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell death
- Blog: Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer’s disease
- Blog: New insights into structure and function of bis-phosphinic acid derivatives and implications for CFTR modulation
- Blog: Exploring the chemical space of the lysine-binding pocket of the first kringle domain of hepatocyte growth factor/scatter factor (HGF/SF) yields a new class of inhibitors of HGF/SF-MET binding
- Blog: Molecular Motions as a Drug Target: Mechanistic Simulations of Anthrax Toxin Edema Factor Function Led to the Discovery of Novel Allosteric Inhibitors
- Blog: Adhirons are efficient tools to guide antiviral ligand discovery
- Blog: Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity
- Blog: Bacterial production and direct functional screening of expanded molecular libraries for discovering inhibitors of protein aggregation
- Blog: Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction
- Blog: Drug Discovery in Low Data Regimes: Leveraging a Computational Pipeline for the Discovery of Novel SARS-CoV-2 Nsp14-MTase Inhibitors
- Blog: High-throughput glycolytic inhibitor discovery targeting glioblastoma by graphite dots–assisted LDI mass spectrometry
- Blog: Functional microRNA-Targeting Drug Discovery by Graph-Based Deep Learning
- Blog: Optimization of Inhibitors of <i>Mycobacterium tuberculosis</i> Pantothenate Synthetase Based on Group Efficiency Analysis
- Blog: Machine Learning Harnesses Molecular Dynamics to Discover New $μ$ Opioid Chemotypes
- Blog: Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates
- Blog: Tetrandrine regulates NAADP-mediated calcium signaling through a LIMP-2-dependent and sphingosine-mediated mechanism
- Blog: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139
- Blog: AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
- Blog: Structure-assisted design of inhibitors targeting coronavirus main proteases
- Blog: Using a Fragment‐Based Approach To Target Protein–Protein Interactions
- Blog: Deep Lead Optimization: Leveraging Generative AI for Structural Modification
- Blog: Screening for FtsZ Dimerization Inhibitors Using Fluorescence Cross-Correlation Spectroscopy and Surface Resonance Plasmon Analysis
- Blog: Mechanisms mediating arylidene-indolinones induced degradation: thoughts on “Discovery of a Drug-like, Natural Product-Inspired, DCAF11 Ligand Chemotype”
- Blog: Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors
- Blog: Deep Lead Optimization: Leveraging Generative AI for Structural Modification
- Blog: Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study
- Blog: Discovery of SIRT7 Inhibitor as New Therapeutic Options Against Liver Cancer
- Blog: Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline scaffold using complementary computational tools
- Blog: Discovery of novel PRMT1 inhibitors: a combined approach using AI classification model and traditional virtual screening
- Blog: Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds
- Blog: Investigation into the Sonodynamic Activity of Three Newly Synthesized Derivatives of Ciprofloxacin
- Blog: Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors
- Blog: Systems analysis reveals a transcriptional reversal of the mesenchymal phenotype induced by SNAIL-inhibitor GN-25
- Blog: Synthesis, cytotoxicity, antioxidant activity and molecular modeling of new NSAIDs-EBS derivatives
- Blog: Discovery, Biological Evaluation and Binding Mode Investigation of Novel Butyrylcholinesterase Inhibitors Through Hybrid Virtual Screening
- Blog: LSD1-Based Reversible Inhibitors Virtual Screening and Binding Mechanism Computational Study
- Blog: Crystal structure, Hirshfeld analysis and a molecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxadiazol-3-yl]methyl}-2<i>H</i>-1,2,6-thiadiazine-4-carboxylate
- Blog: Pharmacophore-based discovery of 2-(phenylamino)aceto-hydrazides as potent eosinophil peroxidase (EPO) inhibitors
- Blog: Identification of novel leishmanicidal molecules by virtual and biochemical screenings targeting Leishmania eukaryotic translation initiation factor 4A
- Blog: Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction
- Blog: A screen for MeCP2-TBL1 interaction inhibitors using a luminescence-based assay
- Blog: Discovery of the Inhibitor Targeting the SLC7A11/xCT Axis through In Silico and In Vitro Experiments
- Blog: Molecular generation strategy and optimization based on A2C reinforcement learning in de novo drug design
- Blog: DiffBindFR: an SE(3) equivariant network for flexible protein–ligand docking
- Blog: Discovery of Novel ROCK1 Inhibitors via Integrated Virtual Screening Strategy and Bioassays
- Blog: FDA-approved phensuximide inhibits RIPK1-dependent immunogenic cell death
- Blog: Importance of N-Terminal Extremity Restriction in the Antiplasmodial Activity of Angiotensin II
- Blog: Inhibition of Nur77 expression and translocation by compound B6 reduces ER stress and alleviates cigarette smoke-induced inflammation and injury in bronchial epithelial cells
Showing 60 of 114 papers.
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_lead_compound_optimization_f1c701aa,
title = {lead compound optimization},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/lead-compound-optimization/rdr_f1c701aa04b1439aad65550d926443f5},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 2, frozen text):
@misc{lacuna_lead_compound_optimization_f1c701aa_v2,
title = {lead compound optimization},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/lead-compound-optimization/rdr_f1c701aa04b1439aad65550d926443f5/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}